Document is current
Any future updates will be listed below
-
Authors
,
Ramu, J
Yang, Y
Menon, G
Bailey, C
Narendran, N
Bunce, C
Quartilho, A
Prevost, A T
Hykin, P
Sivaprasad, S
- License Information
-
More Information
Article History
Received: 14 September 2015
Accepted: 1 October 2015
First Online: 23 October 2015
Competing interests
: YY: consultant—Bayer Healthcare, Alimera Sciences; personal fees—Alcon Inc., Pfizer Inc., Novartis Pharmaceutical, Inc., Allergan Inc., Bayer Healthcare; lecture fees—Bayer Healthcare, Novartis Pharmacueticals, Plc; grant outside the submitted work: Bayer Healthcare, Novartis Pharmaceutical, Inc., Roche Inc.; NN: consultant—Novartis Pharmacuetical, Inc. GM: consultant—Bayer Healthcare, Alcon Inc., Novartis Pharmaceutical, Inc., Allergan Inc.; grant outside the submitted work—Bayer Healthcare; Novartis Pharmaceutical, Inc., Allergan Inc., Alcon Plc, Roche Inc. CB: consultant—Bayer Healthcare, Alimera Sciences, Alcon Inc., Novartis Pharmaceutical, Inc., Allergan Inc.; lecture fees—Bayer Healthcare, Novartis Pharmacueticals, Plc; grant outside the submitted work—Bayer Healthcare; Novartis Pharmaceutical, Inc., Allergan Inc., Alcon Plc, Roche Inc. PH: consultant—Bayer Healthcare, Novartis Pharmaceutical, Inc., Allergan Inc.; lecture fees—Bayer Healthcare, Novartis Pharmacueticals, Plc; grant outside the submitted work—Bayer Healthcare; Novartis Pharmaceutical, Inc., Allergan Inc. SS: consultant—Bayer Healthcare, Novartis Pharmaceutical, Inc., Allergan Inc., Roche Inc.; lecturer—Bayer Healthcare, Novartis Pharmacueticals, Plc, Allergan Plc; grant outside the submitted work—Bayer Healthcare; Novartis Pharmaceutical, Inc., Allergan Inc., Roche Inc. The other authors declare no conflict of interest.
